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INTRODUCTION 
 
 
As of 2010, there were an estimated 285 million visually impaired and 39 million blind individuals 
worldwide [1]. In the United States, proliferative diabetic retinopathy (PDR) and wet age-related 
macular degeneration (AMD) are two of the leading causes of severe vision-loss and blindness [1, 
2]. PDR is a complication of diabetes that is characterized by neovascularization originating from 
the retina and optic disc, that can result in hemorrhage, fibrosis, traction, and retinal detachment 
[3, 4]. An estimated 415 million adults suffer from diabetes globally, and almost half of all 
diabetics are expected to experience some degree of retinopathy [4, 5]. AMD is the leading cause 
of blindness among people aged 55 and older in the developed world and affect more than 1.75 
million individuals in the United States [6, 7]. Wet AMD is characterized by neovascularization, 
that often leads to hemorrhage and exudation. While only 10 percent of AMD patients develop 
wet AMD, severe vision-loss progresses quickly in the majority of these patients [6].  
Vascular endothelial growth factor (VEGF) inhibitors have become standard treatments for 
both PDR and wet AMD [8, 9]. Intravitreal anti-VEGF injection has been shown to significantly 
stabilize visual acuity (VA), with 91.5-95.4% of wet AMD patients in one clinical study showing 
less than a 15-letter decrease in VA [10]. However, anti-VEGF treatment has been suggested to be 
less effective at maintaining VA, and one study showed that 34% of patients experienced a VA 
loss of >15 letters after five years of treatment [11]. One major limitation of anti-VEGF therapy is 
the need for repeated injections on either a monthly or as-needed basis (~6-7 injections per year) 
[4] [10, 13]. In addition to patient anxiety, repeat injections also increase the risk of side effects 
such as endophthalmitis [15]; acute increases in intraocular pressure requiring topical or surgical 
anti-glaucoma interventions [16]; and off-target drug effects including  loss of retinal ganglion 
cells and circulation disturbances in the choriocapillaris [9]. The aforementioned limitations of the 
current clinical standard-of-care and a lack of understanding of the structural, metabolic, and 
vascular changes underlying retinal neovascularization highlights the need to identify mechanisms 
of pathogenesis and novel anti-angiogenic therapies. 
The zebrafish (Danio rerio) is a popular model organism because its fecundity and life cycle 
have enabled development of mutant phenotypes of human pathologies and they are well-suited 
for large scale experiments [17, 18]. As an ophthalmological model, the zebrafish retina shares 
similar structure and function with that of humans and other vertebrates [22]. Similar to humans, 
the zebrafish retina is composed of seven major cell types (six neural and Müller glial cells), three 
nuclear layers separated by two plexiform layers, and a highly ordered mosaic organization of 
neurons in each layer [23, 24]. As diurnal species, humans and zebrafish have cone-dominant 
vision, in contrast to the rod-dominant vision found in mice; this has advantages for studying cone 
degeneration diseases such as AMD [24, 25].  
Zebrafish readily absorb compounds from their aqueous environment and are also affected byt 
them, which allows for induction of pathologies and delivery of chemical compounds without the 
need for injections  [21]. Retinal vasculopathies can be modeled by exposing animals to hypoxic 
water for 3-10 days to induce neovascularization and vascular leakage. Similarly, exposure to 
glucose induces hyperglycemia, which has been shown to result in retinal structural abnormalities 
similar to those in DR [25]. As a pharmacological model, 82% of disease-causing human proteins 
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have orthologues in zebrafish, and pharmacological effects are highly conserved between human 
and zebrafish [26][27][28].  
The majority of drug screens in zebrafish are performed using larval animals because their 
transparency and size are well-suited for imaging and housing in large-scale studies [29]. However, 
normal vascular development [30] and differences in inflammatory and immune responses 
between larva and adults [30] may confound structural and functional changes in larval zebrafish 
models of DR. In this study, we demonstrate in vivo retinal imaging in adult zebrafish (≥3 months 
post-fertilization, mpf) using optical coherence tomography (OCT) [31] and OCT angiography 
(OCT-A) [32] and present post-processing algorithms for vascular segmentation and biometry. 
Quantitative measurements of retinal perfusion and angiogenesis during longitudinal studies can 
provide insights into disease pathogenesis and therapeutic efficacy in drug screens for novel anti-
angiogenic compounds. In addition to tracking functional changes, retinal vascular biometry can 
also be used as a method for uniquely identifying individual animals with high sensitivity and 
specificity. To this end, we developed and validated a novel identification method that obviates 
the need for physical marking methods such as elastomer marking, freeze branding, removal of 
specific scales, fin clipping, and dorsal fin tagging [33]. We believe the retinal vascular biometry 
methods presented here are robust enabling technology that will broadly benefit large-scale 
zebrafish studies.  
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METHODS 
 
 
Imaging system 
OCT and OCT-A imaging of wild-type zebrafish was performed using a custom-built spectral 
domain OCT (SD-OCT) system (Fig. 1(a)). A superluminescent diode (InPhenix) with 855 nm 
central wavelength and 90 nm bandwidth was split between reference and sample arms using an 
80:20 coupler, respectively. The intensity was detected using the central 2048 pixels of a 4096 
pixels linear CMOS array with 125 kHz line-rate (spL4096-140km, Basler). Measured system 
SNR was 107 dB with -6 dB falloff at 1.1 mm and 2.56 µm axial resolution in tissue. Zebrafish 
were imaged using a 1 mm diameter spot size at the pupil with 700 µW of optical power.  
 
Fig. 1. Imaging system. (a) Custom-built SD-OCT system. CMOS, detector; f, 
collimating, objective, ophthalmic, and scan lenses; G, galvanometers; M, mirror; 
PC, polarization controller; SLD, superluminescent diode; VPHG, grating. 
Zebrafish retina were imaged in air through a contact lens and positioned using a 
custom holder (inset). (b) 5-axis alignment stage. 
Imaging protocol 
In vivo imaging was performed under an animal protocol approved by the Institutional Animal 
Care and Use Committee (IACUC) at Cleveland Clinic. Ten adult wild-type zebrafish (≥3 mpf) 
were imaged repeatedly during two sessions on ten different days over four weeks. Both eyes were 
imaged during each imaging session (20 total datasets per eye). Repeat imaging sessions on each 
day were separated by a two-hour break and imaging days were separated by 48 hours.  
Animals were anesthetized prior to imaging using a 0.14% Tricaine solution. Anesthetized 
animals were positioned using a custom holder and the retina was imaged through a contact lens 
(Fig. 1(b)) [41] . Zebrafish OCT and OCT-A volumetric datasets were centered on the optical 
nerve head (ONH) using a 5-axis stage (Fig. 1(b), Leica Microsystems). OCT volumes consisted 
of 2500 B-scans (2048 x 500 pix.) acquired in approximately 10 s. These datasets included five 
repeated B-scans at each lateral position for OCT-A post-processing. Animal imaging and 
handling were performed in less than 10 minutes followed by recovery, during which water was 
forced across the gills to maximize animal survival for the duration of the study [41]. Between 
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imaging days, fish were housed in light exposure and temperature controlled rooms in separate 
boxes and grouped so that individual animals were uniquely identifiable by their strip/spots 
patterns and caudal fin cuts.  
 Vessel segmentation and labeling 
Vessel segmentation, labeling, and feature extraction were performed on en face OCT-A 
projections using custom developed algorithms (Fig. 2). The steps are grouped into four categories 
to better represent the processing pipeline. Each step is described in detail in the following sections. 
 
Fig. 2. Processing algorithm. (a) Algorithm block diagram showing a flow chart of 
vessel segmentation, labeling, and feature extraction; and (b) Processing results in 
each step.  
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Dataset acquisition and processing 
Raw OCT B-scan bulk motions were removed using discrete Fourier transform cross-correlation 
[42]. First, repeated B-scans at the same location were registered to each other. The resulting 
registered B-scans were then averaged, and all of the averaged B-scans in the volumetric dataset 
was registered. Volume registration parameters were calculated using OCT data and applied to the 
corresponding OCT-A frames. 
OCT-A vasculature maps were calculated using weighted optical microangiography (wOMAG) 
[43]. wOMAG uses OCT intensities to remove OCT-A artifacts caused by tissue hyper-
reflectivity. Here, raw optical microangiography (OMAG) frames were weighted by an intensity 
decorrelation function, (D/D0)
n. The decorrelation coefficient, D, represents the intensity 
decorrelation between repeated B-scans, and optimal values for D0 and n were experimentally 
determined (D0 = 0.1, n = 0.5).  
Skeletonization of vascular maps 
En face OCT-A projections were lowpass filtered to smooth vessel contours and remove speckle 
noise. A vertical intensity gradient was also calculated and subtracted from the filtered vessel maps 
to remove breathing artifacts (horizontal streaks). The resulting OCT projections were then 
binarized and skeletonized using dilatation and erosion [44]. Morphological dilatation and erosion 
were performed to expand and compress the binary images. Dilated OCT-A projection was 
performed using a circular kernel (5 pixels radius) for unification of the vessel thickness. This was 
followed by erosion to obtain a one pixel width skeleton. 
Vessel classification and branch point detection 
Skeletonized vasculature maps were used to detect vessel branch points. Vessels were first 
classified as either ONH or retinal vessels. The retinal pigment epithelium (RPE) was segmented 
from OCT cross-sections [45] and the ONH was identified by the discontinuity in the RPE. The 
resulting ONH segmentation was then fit to a circle defined by the ONH center and radius. All 
vessel branches within the ONH radius were classified as ONH vessels and all remaining vessels 
were further processed for branch point identification. 
A set of 18 predefined 3x3 pixel branch kernels was created to represent all possible orientations 
of vessel bifurcation and trifurcation (Fig 3). The spatial location of each vessel branch point was 
identified by convolving the skeletonized vasculature map with each kernel. Branch points were 
then used to classify each vessel segment by branch generation relative to the ONH (Fig. 4). 
 
Fig. 3. Branch kernel matrix. 18 predefined 3x3 pixel kernels were created to 
represent all possible vessel branch orientations.   
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Quantitative vascular biometry 
Quantitative biometry was performed by extracting vessel segment length, curvature, and branch 
angle between branch points in the skeletonized vessel map (Fig. 4). Segment length was defined 
as the total number of pixels in each vessel segment, curvature was calculated as the ratio between 
the vessel segment length and Euclidean distance between corresponding branch points, and angle 
was calculated as the angle between vessel segments. Vascular biometrics were extracted for each 
vessel branch originating from the ONH beginning at the 12 o’clock position and moving 
clockwise around the ONH.  
 
Fig. 4. Quantitative vascular biometry. Angle, curvature, and length were defined 
on skeletonized vascular maps. All branch generations are referenced with respect 
to their connectivity relative to the ONH.  
Retinal vascular biometry for animal identification 
Retinal vascular biometry was evaluated as a robust, noncontact, and noninvasive method for 
unique zebrafish identification over longitudinal timepoints. A Pearson correlation coefficient 
matrix was calculated by comparing vessel branch length, curvature, and angle between all 
datasets. A weight averaged was then used to combine correlation matrices for each generation 
into a single correlation matrix between all datasets. Here, the weighted average favored 
contributions from lower generations to compensate for variability in OCT/OCT-A FOV at 
longitudinal timepoints, which may result in inconsistent biometrics from higher generation vessel 
branches.  
Correlation coefficients in the first-generation matrix above a threshold of 0.957 were exactly 
reproduced in the overall correlation coefficient matrix for the associated fish. Correlation 
coefficients below 0.957 in the first generation were combined with correlation coefficients from 
subsequent generations by a weighted mean method. The optimal threshold of 0.957 was 
empirically determined by calculating sensitivity and specificity at various thresholds. The highest 
sensitivity and specificity occurred at a threshold of 0.957 (Fig. 5).  
Coefficients were assigned relative weights of 6, 7, and 4 for generations 1, 2, and 3, 
respectively. A weight of 2 was assigned for coefficients in generations 4 through 6. The optimal 
weight for each generation was empirically determined by calculating sensitivity and specificity 
values with various weights of coefficients (1-10, sensitivity and specificity values were found to 
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increase to a maximum and then decrease within this range). Correlation coefficients for higher 
generations in fish that did not have branches in these generations were excluded from weighted 
mean calculations. The ten largest overall correlation coefficients for each fish were selected to 
identify the images from the respective ten time points. 
 
Fig. 5. Identification schematic. Every correlation coefficient (Corr Coef) in the 
first generation (Gen 1) matrix was processed in this manner to produce the final 
correlation coefficient in the overall coefficient matrix. After construction of the 
overall coefficient matrix was completed, fish were matched by selecting the 
highest ten (corresponding to the ten time points) correlation coefficients of each 
row.  
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RESULTS 
 
 
In vivo OCT and OCT-A volumes, sampled with 2048 x 500 x 2500 pix. (spectrum x A-scan x 5-
repeated B-scans), were acquired in approximately 10 s. A representative OCT dataset centered 
on the ONH is presented in Figure 6 with cross-sectional retinal layers labeled based on previous 
studies comparing OCT cross-sections to corresponding histology (Fig. 6(b)) [46, 47] 
 
Fig. 6. In vivo retinal OCT in zebrafish. (a) En face OCT projection with 
representative orthogonal cross-sections (blue/red lines and insets). (b) 5-frame 
averaged OCT cross-section with labeled retinal layers. GCL, ganglion cell layer; 
IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; 
ONL, outer nuclear layer; OS, outer segment; and RPE, retinal pigment epithelium.    
The corresponding en face OCT-A projection shows central major vessels radiating outward 
from the ONH (Fig. 7). OCT-A B-scans show vessel cross-sections at the surface of the retina and 
flow artifacts at the RPE below each vessel. We distinguish retinal vessels from artifacts by 
segmenting and isolating only the upper layer of flow signals (Fig. 7(a), arrows) because in the 
adult zebrafish, the retinal vasculature forms a membranous layer that is attached to the vitreal 
interface [48]. 
 
Fig. 7. In vivo retinal OCT-A in zebrafish. (a) En face OCT-A projection with 
representative orthogonal cross-sections (blue/red lines and insets) showing retinal 
vessels (arrow) and RPE artifacts. (b) OCT-A projection with corresponding 
segmentation mask overlay. Vessel branches are color-coded based on their branch 
generation relative to the ONH (white circle). 
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OCT-A vessel maps were skeletonized and the resulting vessel segments were color-coded to 
represent different branches relative to the ONH (Fig. 7(b)). Any skeletonized vessel segments 
that begin and end within the ONH (white circle) were ignored. Vessels that begin inside and end 
outside of the ONH were considered the first branch generation (green) and branch generations 
were incremented radially outward from the ONH. Total processing time for each OCT-A dataset 
was approximately 13 minutes, the bulk of which was spent on volumetric registration (>12 min.). 
Skeletonization and vessel segmentation was performed in ~30 s per vascular map. 
Automatically segmented vessel maps were evaluated by manual graders to quantify the 
robustness of our algorithm. Errors were identified in 2.5% of data (5 of 200 vessel maps) and 
classified as either segmentations errors at the periphery of the FOV (Fig. 8) or inside the ONH 
(Fig. 9). Figures 8 and 9 show longitudinal datasets in the same eye to highlight these segmentation 
errors. At the edge of the FOV, segmentation is confounded by areas of low OCT-A contrast and 
cropped vessel branches. Poor contrast results in missed branches and branch points (Fig. 8, pink 
arrows). Similarly, vessels cropped at the end of the imaging FOV may result in missed branch 
points (Fig. 8, orange arrows). Missing branches or branch points confound all downstream 
analyses, including branch generation labeling and quantification of branch length, angle, and 
curvature. Mislabeled branch generations also occurred because of overlap between a vessel 
branch point and the ONH rim. In these cases, there was ambiguity in classifying the vessel 
segment as either a retinal or ONH vessel, which led to the mislabeling of subsequent branch 
generations originating from the initial mislabeled ONH branch (Fig. 9). 
 
Fig. 8. Segmentation errors at the FOV periphery. Representative en face (a), (d) 
OCT, (b), (e) OCT-A, and (c), (f) segmentation maps at two longitudinal 
timepoints. Generation 3 branches, which are identified are misidentified as part of 
the preceding generation 2 branch because of poor contrast (pink arrows). 
Similarly, vessel branches cropped by the edge of the FOV with sufficient contrast 
may be misidentified as part of the preceding generation (orange arrows).  
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Automatically extracted quantitative vascular biometrics were color-coded and plotted as maps 
of vessel branch angle, curvature, and length to enable qualitative comparisons between 
longitudinal data and eyes (Fig. 10).  Biometrics were grouped by left (OS) and right (OD) eye in 
each fish, and all 10 repeated longitudinal datasets in each eye were shown as vertical columns. In 
the horizontal axis, branch segments (row) were grouped by branch generations. Visibly, the 
biometric data becomes noisier in higher generation vessel branches because of aforementioned 
segmentation errors at the edge of the FOV. Within each eye, similar biometric patterns are 
observed in repeated datasets for each eye, but data between different eyes and different fish are 
significantly different.  
 
Fig. 9. Segmentation errors at the ONH. (a)-(c) En face OCT-A, (d)-(f) 
segmentation maps, and (g)-(i) magnified views around the ONH at three 
longitudinal timepoints. (d), (g) Correctly labeled datasets show ONH vessels in 
gray. (e), (g), (f), (i) Branch generation labeling errors show ONH vessels labeled 
as first-generation vessels (green).  
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Fig. 10. Quantitative vascular biometry. Vessel branch (a) angle, (b) curvature, and 
(c) length of 10 repeated longitudinal datasets (columns) for both eyes of 10 
zebrafish (column groups). Biometrics in each eye were grouped by branch 
generation (row groups) and each row shows biometric data from each vessel in the 
respective generation.  
Branch vessel length was identified as the most robust biometric parameter for comparing 
vascular data between longitudinal timepoints because it has the highest dynamic range and lowest 
noise of all three parameters (Fig 10.). When comparing branch vessel lengths, higher order 
generations (>3) were given lower weights because of increased noise as compared to the first two 
generations (Fig. 11). The increased noise is attributed to differences in imaging FOV between 
longitudinal timepoints that result in different higher generation branch vessels being visible (Fig. 
11(b)-(d)).   
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Fig. 11. Vessel branch length comparison between longitudinal timepoints. (a) 
Representative biometric map showing vessel branch length differences between 
10 repeated datasets in one eye. (b)-(d) Segmented vascular maps at 3 timepoints 
showing similar length parameters in the first and second vessel generations and 
increased noise in higher generations as a result of FOV differences (asterisk).       
As explained in the methods, the identification process uses only first generation cross-
correlation coefficients higher or equal to 0.957. This assumption is reasonable because the first 
generation is more robust to the changes in images between imaging time points. FOV changes 
influence first generation feature parameters slightly because they start inside the ONH and in most 
cases they have branching inside the field of view. Although not all first-generation vessels branch 
inside the FOV, errors in these cases are relatively small with respect to vessel length and do not 
influence angle measurements at all. Curvature is influenced by such errors only if the missing 
part of the vessel has a strong curve in that area. On the other hand, the dynamic range of feature 
values (especially for length) is much higher than in other generations (Fig 10.). This allows us to 
consider the first-generation as more robust compared to the others. Figure 12 illustrates changes 
between two eyes in the first generation.  
As described above we decided to weight higher the first branch generation of blood vessel 
features for automatic identification based on the higher relative change in the features across fish 
as compared to higher generations. Changes in higher order generations may be influenced by eye 
position in the field of view (FOV) in images, leading to segmentation errors. Prior to manually 
fixing these errors, a specificity of 99.82% and a sensitivity of 96.5% was achieved.  
After applying the weighted algorithm to the manually corrected dataset, 1986 out of 2000 
matches (20 eyes, 10 matches for each eye) were identified correctly (99.3% sensitivity). 37986 
out of 38000 matches were correctly identified as mismatches (99.96% specificity). Overall, 18 
out of 20 eyes matched all ten timepoints correctly. The remaining two eyes had images from two 
timepoints each that did not match completely with all of the other timepoints of the associated 
fish (14 images in total that did not match correctly).  
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Fig. 12. First generation length differences between eyes. (a) and (c) represent 
length of each segment in the first generation of the two eyes. (b) and (d) shows 
vasculature maps of those two eyes. Black arrows point out differences between 
segments on the eyes. Black asterisk denote segment that appear on one eye but  
not on the other. 
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DISCUSION AND CONCLUSION 
 
 
A novel zebrafish identification method has been presented that is efficient and robust. Total 
processing time for vascular segmentation and labeling was ~30 s, and the identification algorithm 
showed a sensitivity and specificity above 99%. The algorithm correctly identified 18 out of 20 
eyes in each imaging session. The proposed method addresses major limitations in large population 
imaging studies of adult zebrafish, specifically the need to uniquely identify animals between 
longitudinal timepoints. The ability to uniquely identify eyes with high specificity and sensitivity 
reduces the need for fin cutting and housing animals in limited groups (4-5 fish) to enable 
identification based on natural markings. OCT-A is demonstrated to provide functional 
information to enable quantitative biometrics in zebrafish models of retinal vascular pathologies.  
In the preliminary study, identification errors were primarily a result of differences in FOV 
between longitudinal timepoints. Translational differences in FOV between timepoints affects the 
vessel branches that are visible, which contributes to increased noise in biometric parameters for 
higher order generations. Rotational differences of the FOV at different timepoints also limits the 
accuracy of biometric comparisons because branch vessels may be mislabeled between datasets. 
Both sources of error may be addressed using volumetric registration of images at different 
timepoints at the expense of computational complexity and time. FOV differences also introduced 
segmentation errors. Vessel branches that are cropped at the edge of the FOV may cause branch 
points to be missed during automatic feature identification. The current algorithm defines branch 
points as the point where a parent branch ramifies into two or three children branches. Loss of 
children branches by FOV cropping can result in parent and a child branch to be considered as a 
single vessel branch, thus resulting in significant errors in biometric quantification (Fig. 10). A 
potential solution for overcoming these errors may be to omit any higher generation branch vessels 
that intersect the FOV edge to avoid the potential for associated errors. ONH segmentation errors 
were also observed between timepoints. Inaccurate identification of ONH vessels resulted in vessel 
generation labeling errors for all subsequent branch vessels. One possible solution for ONH vessel 
segmentation errors may be to appropriately threshold for first generation branches because ONH 
vessels are significantly shorter than first generation vessels. 
The major bottleneck of the current algorithm is volumetric registration, which was ~12 min 
per volume. However, registration does not significantly limit the utility of the method because it 
is performed during post-processing and therefore real-time operation is not required. In addition, 
it was determined that registration of repeated OCT-A frames at the same position was not 
necessary in all fish. Thus, increased OCT/OCT-A imaging speeds may obviate the need for 
volumetric registration to remove bulk motion noise. 
 Demonstration of the use of OCT and OCT-A for structural and functional imaging of zebrafish 
retina has been accomplished. Quantitative vascular biometry was extracted from automatically 
segmented vessels from OCT-A and used to uniquely identify eyes in different fish between 
longitudinal timepoints. Identification accuracy of 99.3% was achieved in a preliminary study of 
wild-type fish over 10 repeated timepoints. The developed technology eliminates the need to 
manually mark and identify animals and provides quantitative metrics for studying functional 
changes in zebrafish models of retinal pathologies.  
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